Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cognition Disorders | 15 | 2018 | 388 | 2.460 |
Why?
|
Brain | 18 | 2018 | 809 | 2.240 |
Why?
|
Diabetes Mellitus, Type 2 | 23 | 2018 | 1556 | 2.090 |
Why?
|
Aging | 8 | 2015 | 857 | 1.600 |
Why?
|
Cognition | 12 | 2019 | 512 | 1.560 |
Why?
|
Auditory Perception | 8 | 2009 | 30 | 1.320 |
Why?
|
Attention | 6 | 2009 | 61 | 1.200 |
Why?
|
Magnetic Resonance Imaging | 16 | 2018 | 1144 | 1.060 |
Why?
|
Visual Perception | 7 | 2009 | 35 | 0.980 |
Why?
|
Caloric Restriction | 2 | 2019 | 92 | 0.820 |
Why?
|
Neuropsychological Tests | 12 | 2019 | 370 | 0.680 |
Why?
|
Aged | 29 | 2019 | 9256 | 0.640 |
Why?
|
Exercise | 2 | 2019 | 567 | 0.620 |
Why?
|
Obesity | 3 | 2019 | 1079 | 0.620 |
Why?
|
Exercise Therapy | 1 | 2019 | 195 | 0.610 |
Why?
|
Female | 34 | 2019 | 17679 | 0.500 |
Why?
|
Humans | 40 | 2019 | 28304 | 0.490 |
Why?
|
Diabetic Retinopathy | 1 | 2014 | 69 | 0.490 |
Why?
|
Glucose Metabolism Disorders | 1 | 2013 | 3 | 0.480 |
Why?
|
Cerebrovascular Disorders | 1 | 2013 | 45 | 0.470 |
Why?
|
Pain | 1 | 2015 | 247 | 0.460 |
Why?
|
Male | 30 | 2019 | 16967 | 0.450 |
Why?
|
Mobility Limitation | 1 | 2014 | 180 | 0.440 |
Why?
|
Middle Aged | 25 | 2019 | 10678 | 0.440 |
Why?
|
Adult | 19 | 2016 | 8243 | 0.430 |
Why?
|
Cerebral Cortex | 2 | 2009 | 82 | 0.420 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2012 | 31 | 0.410 |
Why?
|
African Americans | 8 | 2018 | 1513 | 0.400 |
Why?
|
Coronary Artery Disease | 2 | 2015 | 379 | 0.380 |
Why?
|
Alzheimer Disease | 1 | 2013 | 291 | 0.370 |
Why?
|
Sensation | 1 | 2009 | 17 | 0.350 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2007 | 111 | 0.350 |
Why?
|
Acoustic Stimulation | 7 | 2009 | 57 | 0.340 |
Why?
|
Photic Stimulation | 7 | 2009 | 56 | 0.340 |
Why?
|
Cues | 4 | 2009 | 34 | 0.330 |
Why?
|
Dementia | 3 | 2015 | 231 | 0.330 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2017 | 272 | 0.320 |
Why?
|
Brain Mapping | 5 | 2014 | 134 | 0.320 |
Why?
|
Biomedical Research | 1 | 2008 | 144 | 0.300 |
Why?
|
Imaging, Three-Dimensional | 1 | 2007 | 128 | 0.290 |
Why?
|
Risk Factors | 8 | 2018 | 3520 | 0.250 |
Why?
|
Estrogen Replacement Therapy | 2 | 2015 | 183 | 0.250 |
Why?
|
Reaction Time | 5 | 2009 | 70 | 0.230 |
Why?
|
Cross-Sectional Studies | 6 | 2018 | 1345 | 0.230 |
Why?
|
Brain Diseases | 2 | 2014 | 39 | 0.220 |
Why?
|
Organ Size | 5 | 2018 | 204 | 0.220 |
Why?
|
Genome-Wide Association Study | 2 | 2016 | 615 | 0.220 |
Why?
|
European Continental Ancestry Group | 6 | 2018 | 1203 | 0.220 |
Why?
|
Albuminuria | 4 | 2017 | 207 | 0.210 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2016 | 1236 | 0.210 |
Why?
|
Aged, 80 and over | 10 | 2016 | 3562 | 0.200 |
Why?
|
Models, Neurological | 2 | 2014 | 63 | 0.200 |
Why?
|
Auditory Cortex | 3 | 2009 | 16 | 0.190 |
Why?
|
Diabetes Complications | 3 | 2018 | 184 | 0.180 |
Why?
|
Genetic Association Studies | 3 | 2016 | 171 | 0.180 |
Why?
|
Cohort Studies | 7 | 2018 | 1673 | 0.180 |
Why?
|
Analysis of Variance | 3 | 2009 | 390 | 0.180 |
Why?
|
Executive Function | 1 | 2019 | 51 | 0.180 |
Why?
|
Task Performance and Analysis | 2 | 2009 | 36 | 0.170 |
Why?
|
Blood Glucose | 3 | 2019 | 485 | 0.170 |
Why?
|
Cardiovascular Diseases | 3 | 2017 | 1059 | 0.170 |
Why?
|
Estrogens, Conjugated (USP) | 2 | 2015 | 125 | 0.160 |
Why?
|
Sex Characteristics | 1 | 2018 | 158 | 0.160 |
Why?
|
Young Adult | 3 | 2014 | 2321 | 0.150 |
Why?
|
Postmenopause | 2 | 2015 | 398 | 0.140 |
Why?
|
Overweight | 1 | 2018 | 254 | 0.140 |
Why?
|
Aromatic-L-Amino-Acid Decarboxylases | 1 | 2016 | 5 | 0.140 |
Why?
|
Apolipoproteins E | 1 | 2016 | 101 | 0.140 |
Why?
|
Dopamine | 1 | 2016 | 42 | 0.140 |
Why?
|
Spectrin | 1 | 2014 | 6 | 0.130 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2014 | 14 | 0.130 |
Why?
|
Vascular Diseases | 1 | 2015 | 60 | 0.130 |
Why?
|
Prevalence | 2 | 2018 | 881 | 0.130 |
Why?
|
Arachidonic Acid | 2 | 2011 | 38 | 0.130 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2014 | 52 | 0.130 |
Why?
|
Anxiety | 1 | 2015 | 132 | 0.130 |
Why?
|
Glomerular Filtration Rate | 4 | 2017 | 307 | 0.120 |
Why?
|
Genetic Predisposition to Disease | 2 | 2014 | 938 | 0.120 |
Why?
|
Cerebrovascular Circulation | 2 | 2015 | 90 | 0.120 |
Why?
|
Nerve Net | 1 | 2014 | 88 | 0.110 |
Why?
|
Tomography, Spiral Computed | 1 | 2013 | 19 | 0.110 |
Why?
|
Depression | 1 | 2015 | 361 | 0.110 |
Why?
|
Signal Transduction | 1 | 2016 | 607 | 0.110 |
Why?
|
Longitudinal Studies | 1 | 2014 | 694 | 0.110 |
Why?
|
Visual Cortex | 2 | 2009 | 20 | 0.110 |
Why?
|
Diabetic Nephropathies | 1 | 2014 | 246 | 0.110 |
Why?
|
Heart Ventricles | 1 | 2013 | 115 | 0.110 |
Why?
|
Treatment Outcome | 1 | 2019 | 2886 | 0.100 |
Why?
|
United States | 6 | 2018 | 3588 | 0.100 |
Why?
|
Stearoyl-CoA Desaturase | 1 | 2011 | 15 | 0.100 |
Why?
|
Gene Regulatory Networks | 1 | 2011 | 35 | 0.100 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2011 | 30 | 0.100 |
Why?
|
Fatty Acid Desaturases | 1 | 2011 | 45 | 0.100 |
Why?
|
Proportional Hazards Models | 2 | 2013 | 706 | 0.100 |
Why?
|
Computational Biology | 1 | 2011 | 87 | 0.100 |
Why?
|
Prognosis | 1 | 2014 | 1342 | 0.090 |
Why?
|
Stroke Volume | 1 | 2013 | 278 | 0.090 |
Why?
|
Science | 1 | 2010 | 8 | 0.090 |
Why?
|
Ethics, Research | 1 | 2010 | 25 | 0.090 |
Why?
|
Social Responsibility | 1 | 2010 | 13 | 0.090 |
Why?
|
Teaching | 1 | 2010 | 55 | 0.090 |
Why?
|
Research | 1 | 2010 | 67 | 0.090 |
Why?
|
Noise | 1 | 2009 | 3 | 0.090 |
Why?
|
Fixation, Ocular | 1 | 2009 | 4 | 0.090 |
Why?
|
Space Perception | 1 | 2009 | 12 | 0.090 |
Why?
|
Kidney Failure, Chronic | 1 | 2014 | 578 | 0.090 |
Why?
|
Environment | 1 | 2009 | 44 | 0.090 |
Why?
|
Perceptual Disorders | 1 | 2009 | 5 | 0.090 |
Why?
|
Laboratories | 1 | 2008 | 13 | 0.090 |
Why?
|
Behavior | 1 | 2008 | 22 | 0.080 |
Why?
|
Psychomotor Performance | 1 | 2008 | 59 | 0.080 |
Why?
|
Curriculum | 1 | 2010 | 189 | 0.080 |
Why?
|
Adolescent | 4 | 2009 | 3184 | 0.080 |
Why?
|
Sensory Thresholds | 1 | 2007 | 20 | 0.080 |
Why?
|
Evoked Potentials, Auditory | 1 | 2007 | 4 | 0.080 |
Why?
|
Mental Processes | 1 | 2007 | 10 | 0.080 |
Why?
|
Echo-Planar Imaging | 1 | 2007 | 16 | 0.080 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2009 | 229 | 0.080 |
Why?
|
Perception | 1 | 2007 | 64 | 0.080 |
Why?
|
Age Factors | 1 | 2009 | 1058 | 0.070 |
Why?
|
Creatinine | 2 | 2017 | 183 | 0.070 |
Why?
|
Linear Models | 2 | 2017 | 421 | 0.060 |
Why?
|
Diabetic Angiopathies | 2 | 2015 | 150 | 0.060 |
Why?
|
Kidney Function Tests | 2 | 2015 | 108 | 0.060 |
Why?
|
Risk | 2 | 2015 | 290 | 0.060 |
Why?
|
Animals | 1 | 2015 | 6402 | 0.060 |
Why?
|
Hypertension | 3 | 2017 | 978 | 0.060 |
Why?
|
Genotype | 2 | 2016 | 813 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2015 | 441 | 0.060 |
Why?
|
8,11,14-Eicosatrienoic Acid | 2 | 2011 | 13 | 0.050 |
Why?
|
Gene Frequency | 2 | 2011 | 272 | 0.050 |
Why?
|
Fatigue | 1 | 2019 | 68 | 0.040 |
Why?
|
Oxygen Consumption | 1 | 2019 | 138 | 0.040 |
Why?
|
Exercise Test | 1 | 2019 | 192 | 0.040 |
Why?
|
Exercise Tolerance | 1 | 2019 | 110 | 0.040 |
Why?
|
Disability Evaluation | 1 | 2019 | 202 | 0.040 |
Why?
|
Behavior Therapy | 1 | 2018 | 89 | 0.040 |
Why?
|
Heterozygote | 1 | 2016 | 54 | 0.040 |
Why?
|
Cholesterol, LDL | 1 | 2017 | 165 | 0.040 |
Why?
|
Minisatellite Repeats | 1 | 2016 | 10 | 0.040 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 1 | 2016 | 13 | 0.040 |
Why?
|
Life Style | 1 | 2018 | 372 | 0.030 |
Why?
|
Pedigree | 1 | 2016 | 149 | 0.030 |
Why?
|
Body Mass Index | 1 | 2019 | 890 | 0.030 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2015 | 87 | 0.030 |
Why?
|
Magnetic Resonance Angiography | 1 | 2015 | 59 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2017 | 631 | 0.030 |
Why?
|
Medroxyprogesterone Acetate | 1 | 2015 | 89 | 0.030 |
Why?
|
Memory | 1 | 2016 | 175 | 0.030 |
Why?
|
Stroop Test | 1 | 2014 | 6 | 0.030 |
Why?
|
Albumins | 1 | 2014 | 38 | 0.030 |
Why?
|
Atrophy | 1 | 2014 | 51 | 0.030 |
Why?
|
Glucose | 1 | 2015 | 163 | 0.030 |
Why?
|
Smoking | 1 | 2017 | 389 | 0.030 |
Why?
|
Estrogens | 1 | 2015 | 170 | 0.030 |
Why?
|
Heart Diseases | 1 | 2014 | 101 | 0.030 |
Why?
|
Educational Status | 1 | 2014 | 162 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2015 | 886 | 0.030 |
Why?
|
Cardiac-Gated Imaging Techniques | 1 | 2013 | 14 | 0.030 |
Why?
|
Phenotype | 1 | 2014 | 653 | 0.030 |
Why?
|
ROC Curve | 1 | 2013 | 146 | 0.030 |
Why?
|
Incidence | 1 | 2015 | 1087 | 0.030 |
Why?
|
Siblings | 1 | 2011 | 24 | 0.030 |
Why?
|
Eicosapentaenoic Acid | 1 | 2011 | 27 | 0.030 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2011 | 26 | 0.030 |
Why?
|
Multigene Family | 1 | 2011 | 49 | 0.030 |
Why?
|
North Carolina | 1 | 2015 | 1412 | 0.030 |
Why?
|
Family Health | 1 | 2011 | 86 | 0.030 |
Why?
|
Linkage Disequilibrium | 1 | 2011 | 222 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 774 | 0.020 |
Why?
|
Education, Graduate | 1 | 2010 | 3 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2015 | 2027 | 0.020 |
Why?
|
Functional Laterality | 1 | 2008 | 47 | 0.020 |
Why?
|
Electrocardiography | 1 | 2013 | 568 | 0.020 |
Why?
|
Regression Analysis | 1 | 2008 | 266 | 0.020 |
Why?
|
Color Perception | 1 | 2007 | 2 | 0.020 |
Why?
|
Sample Size | 1 | 2007 | 37 | 0.020 |
Why?
|
Reference Values | 1 | 2007 | 227 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2007 | 95 | 0.020 |
Why?
|
Computer Simulation | 1 | 2007 | 187 | 0.020 |
Why?
|
Models, Statistical | 1 | 2007 | 157 | 0.020 |
Why?
|